BioXell Initiates Phase II Clinical Trial with BXL-628 in Benign Prostatic Hyperplasia
27 mars 2003 07h25 HE
|
BioXell SpA
MILAN, Italy, March 27, 2003 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company, today announced that it has initiated recruitment for the Phase II trial of its novel lead compound,...
BioXell Appoints Alex Martin as Chief Business Officer
08 janv. 2003 04h52 HE
|
BioXell SpA
MILAN, Italy, Jan. 8, 2003 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company focused on immunology, today announced the appointment of Alex Martin as Chief Business Officer. Mr Martin...
BioXell Announces an Exclusive Collaboration with TaiGen
09 sept. 2002 04h47 HE
|
BioXell SpA
MILAN, Italy, Sept. 9, 2002 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company focused on immunology, today announced an exclusive joint collaboration agreement with TaiGen...
BioXell Listed by Tornado Insider as One of Europe's Top 100 Start-Ups
18 juil. 2002 06h13 HE
|
BioXell SpA
MILAN, Italy, July 18, 2002 (PRIMEZONE) -- July 2002 BioXell S.p.A. was recently named in the second annual "Tornado Insider 100" list as one of Europe's top emerging private tech companies. BioXell,...
BioXell Appoints Dr. Bernd Seizinger to Board of Directors
02 juil. 2002 07h20 HE
|
BioXell SpA
MILAN, Italy, July 2, 2002 (PRIMEZONE) -- BioXell SpA, the Italian biopharmaceutical company focused on immunology, today announced the appointment of Professor Bernd Seizinger to the Board of...
BioXell Announces the Discovery of a Receptor Implicated in the Development of Chronic Obstructive Pulmonary Disease
26 juin 2002 06h17 HE
|
BioXell SpA
MILAN, Italy, June 26, 2002 (PRIMEZONE) -- BioXell SpA today announced the publication of a study in the May issue of The American Journal of Respiratory and Critical Care Medicine on the...
BioXell Announces the Formation of its Scientific Advisory Board
06 juin 2002 06h23 HE
|
BioXell SpA
MILAN, Italy, June 6, 2002 (PRIMEZONE) -- BioXell SpA, the recently-formed Italian biopharmaceutical company focused on immunology, today announced the formation of its Scientific Advisory Board. The...
BioXell SpA: Vitamin D3 Analogue Arrests the Development of Autoimmune Diabetes
26 avr. 2002 07h27 HE
|
BioXell SpA
MILANO, Italy, April 26, 2002 (PRIMEZONE) -- BioXell SpA announced today the publication of a study in the May issue of the journal Diabetes describing the ability of a synthetic analogue of the...
BioXell: New Immunology Company Launched; Roche Spin-Out Raises Euro 22 Million from International Investors
26 mars 2002 07h56 HE
|
BioXell SpA
MILAN, Italy, March 26, 2002 (PRIMEZONE) -- BioXell SpA announced its official launch today at a press conference in Milan. The firm combines extensive industry experience with a competitive edge in...